Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
3.370
+0.010 (0.30%)
At close: Mar 11, 2026, 4:00 PM EDT
3.360
-0.010 (-0.30%)
After-hours: Mar 11, 2026, 5:48 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $204.13 million as of March 11, 2026. Its market cap has increased by 144.44% in one year.
Market Cap
204.13M
Enterprise Value
98.92M
1-Year Change
144.44%
Ranking
Category
Stock Price
$3.37
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $204.13M, a decrease of -66.99%. That is a compound annual growth rate of -21.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 203.53M | 59.24% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 218.00M |
| Arcturus Therapeutics Holdings | 216.58M |
| Compugen | 211.80M |
| SAB Biotherapeutics | 208.90M |
| Zentalis Pharmaceuticals | 198.14M |
| Galectin Therapeutics | 197.29M |
| Caribou Biosciences | 196.17M |
| ProMIS Neurosciences | 194.51M |